Amgen files update to Tavneos label as FDA escalates push to withdraw
Amgen has taken steps to update its Tavneos label amid an ongoing battle with the FDA. The company filed a supplement on Wednesday that would add more information to the warning ...
ORIGINAL SOURCE →via Endpoint News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · conflict
- [CONFLICT] Intermodal Asia
- [CONFLICT] Securing the Untrusted Agentic Development Layer
- [CONFLICT] [World Report] Health on the ballot in Senedd Cymru election
- [CONFLICT] [Perspectives] Amita Aggarwal: understanding autoimmune rheumatic diseases
- [CONFLICT] [Perspectives] Of memory, love, death, and Proust
- [CONFLICT] [Perspectives] Myopic medical harm: a man receives free colon cancer screening in Ghana